Search Result "chronic myelogenous leukaemia."
Chronic Myelogenous Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 3-13
Author(s): Robert P. Hasserjian
Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors
Journal: Current Pharmacogenomics
Volume: 5 Issue: 3 Year: 2007 Page: 201-213
Author(s): Helene Labussiere, Sandrine Hayette, Franck E. Nicolini
Bypass Mechanisms of Resistance to Tyrosine Kinase Inhibition in Chronic Myelogenous Leukaemia
Journal: Current Drug Discovery Technologies
Volume: 11 Issue: 2 Year: 2014 Page: 145-153
Author(s): Gabriella Marfe,Carla Di Stefano
Rho-Signaling Pathways in Chronic Myelogenous Leukemia
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8 Issue: 4 Year: 2008 Page: 261-267
Author(s): Katerina Kuzelova, Zbynek Hrkal
Treatment of Relapsed Acute Myeloid Leukaemia
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 103-111
Author(s): Jonathan Kell
Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 631-646
Author(s): G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud, B. T. Gjertsen
Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 724-734
Author(s): Gudmundur V. Helgason, Arunima Mukhopadhyay, Maria Karvela, Paolo Salomoni, Bruno Calabretta, Tessa L. Holyoake
Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 1 Year: 2013 Page: 69-79
Author(s): J. Kuroda,Y. Shimura,M. Yamamoto-Sugitani,N. Sasaki,M. Taniwaki
The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer
Journal: Current Cancer Drug Targets
Volume: 1 Issue: 1 Year: 2001 Page: 49-57
Author(s): Michael E. ODwyer, Brian J. Druker
Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 530-536
Author(s): Massimo Breccia, Giuliana Alimena